EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke Outcomes

Umberto Pensato iD, Johanna M Ospel iD, Jianhai Zhang iD, Kazbek Barakhanov iD, Koji Tanaka iD, Fouzi Bala iD, Chitapa Kaveeta iD, Diana Kim iD, Michel Shamy iD, MacKenzie Horn iD, Thalia S Field iD, Brian H Buck iD und 9 weitere

Journal of the American Heart Association · 04.11.2025 · 14 (21)

DOI: 10.1161/jaha.125.044246 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 04.11.2025. Verfasst von Umberto Pensato und 20 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Humanitas Research Hospital Milan Italy. Hauptthemen laut MEDLINE: Ischemic Stroke, Fibrinolytic Agents, Tissue Plasminogen Activator, Minimal Clinically Important Difference. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infarct volume is an imaging biomarker of ischemic tissue injury strongly correlated with poststroke outcomes and reperfusion benefit. We aimed to evaluate the follow‐up infarct volume (FIV) difference corresponding to a 1%, 5%, and 10% increase in probability of excellent functional outcomes after intravenous thrombolysis.

Methods

Data are from the AcT trial (Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke). Patients with 24‐hour infarct volume segmentations were included. The primary outcome was excellent functional outcome (modified Rankin Scale score=0–1). Associations between outcomes and FIV were investigated with regression analyses adjusted for covariates. Sensitivity analyses examined patients with noncontrast computed tomography versus magnetic resonance imaging follow‐up and those treated versus not treated with endovascular thrombectomy.

Results

The study included 1478 patients (median age 74 years [interquartile range (IQR), 63–83], 48.2% female). Median FIV was 2.7 mL (IQR, 0–18.2), and 527 (35.7%) achieved excellent functional outcome. FIV was associated with excellent functional outcome: adjusted odds ratio, 0.97 (95% CI, 0.96–0.98) per 1‐mL FIV increase. The median ΔFIV corresponding to a 1%, 5%, and 10% increase in adjusted probability of excellent functional outcomes were 1.5 mL (IQR, 1.4–1.9), 7.3 mL (IQR, 6.8–9.3), and 14.6 mL (IQR, 13.6–18.2), respectively. Results were consistent across follow‐up imaging modality and endovascular thrombectomy subgroups.

Conclusions

In patients with acute ischemic stroke treated with intravenous thrombolysis, differences of ~1.5 mL, ~7 mL, and ~15 mL in FIV corresponded to a 1%, 5%, and 10% higher absolute probability of achieving excellent functional outcomes. These findings could inform the design of future clinical Phase 2 and proof‐of‐principle stroke trials that aim to use FIV as a key outcome measure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeFibrinolytic AgentsTissue Plasminogen ActivatorMinimal Clinically Important DifferenceThrombolytic TherapyTenecteplaseStrokeHumansFemaleMaleAgedMiddle AgedAged, 80 and overTreatment OutcomeMagnetic Resonance ImagingTomography, X-Ray ComputedThrombectomyEndovascular ProceduresRecovery of Function

Stichwörter der Autor:innen

cerebral infarct growthfunctional outcomesneuroprotectiontenecteplasethrombectomy

Substanzen

Fibrinolytic AgentsTissue Plasminogen ActivatorTenecteplase

Autor:innen und Institutionen

  • IRCCS Humanitas Research Hospital Milan Italy.
  • Department of Biomedical Sciences Humanitas University Milan Italy.
  • Department of Clinical Neurosciences University of Calgary AB Canada.
  • Department of Radiology University of Calgary AB Canada.
  • Diagnostic and Interventional Neuroradiology Department University Hospital of Tours Tours France.
  • Department of Medicine, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand.

ORCID-Profile: Umberto Pensato, Johanna M Ospel, Jianhai Zhang, Kazbek Barakhanov, Koji Tanaka, Fouzi Bala, Chitapa Kaveeta, Diana Kim, Michel Shamy, MacKenzie Horn, Thalia S Field, Brian H Buck, Aleks Tkach, Luciana Catanese, Rick H Swartz, Tolulope Sajobi, Mohammed Almeklhafi, Andrew M Demchuk, Bijoy K Menon, Aravind Ganesh, Nishita Singh

Zitieren

APA

Pensato, U., Ospel, J. M., Zhang, J., Barakhanov, K., Tanaka, K., Bala, F., Kaveeta, C., Kim, D., Shamy, M., Horn, M., Field, T. S., Buck, B. H., Tkach, A., Catanese, L., Swartz, R. H., Sajobi, T., Almeklhafi, M., Demchuk, A. M., Menon, B. K., …, & Singh, N. (2025). Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke Outcomes. Journal of the American Heart Association, 14(21). https://doi.org/10.1161/jaha.125.044246

Vancouver

Pensato U, Ospel JM, Zhang J, Barakhanov K, Tanaka K, Bala F, et al. Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke Outcomes. Journal of the American Heart Association. 2025;14(21). doi:10.1161/jaha.125.044246

BibTeX
@article{Pensato2025,
  author = {Pensato, Umberto and Ospel, Johanna M and Zhang, Jianhai and Barakhanov, Kazbek and Tanaka, Koji and Bala, Fouzi and Kaveeta, Chitapa and Kim, Diana and Shamy, Michel and Horn, MacKenzie and Field, Thalia S and Buck, Brian H and Tkach, Aleks and Catanese, Luciana and Swartz, Rick H and Sajobi, Tolulope and Almeklhafi, Mohammed and Demchuk, Andrew M and Menon, Bijoy K and Ganesh, Aravind and Singh, Nishita},
  title = {Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke Outcomes},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {21},
  doi = {10.1161/jaha.125.044246}
}
Kostenlos starten →